Topaz Pharmaceuticals LLC – Trademark Portfolio

Entity Type: 16

Topaz Pharmaceuticals LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SKLICE. The owner is based in Horsham, PA.

100 Witmer Road, Suite 280

Horsham, PA 19044

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TOPAZ
TOPAZ
Cancelled 2008
MECTAGON
MECTAGON
Abandoned 2007
LICIDIN
LICIDIN
Abandoned 2007
PEDINOX
PEDINOX
Abandoned 2007
PEDECTIN
PEDECTIN
Abandoned 2007
SKLICE
SKLICE
Registered 2005
TOPAZ
TOPAZ
Cancelled 2005

Trademark Classifications

Topaz Pharmaceuticals LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Topaz Pharmaceuticals LLC have?

Topaz Pharmaceuticals LLC has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 2 cancelled.

What trademark classes does Topaz Pharmaceuticals LLC file in?

Topaz Pharmaceuticals LLC files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Topaz Pharmaceuticals LLC's most well-known trademarks?

Topaz Pharmaceuticals LLC's registered trademark portfolio includes well-known marks such as SKLICE. These are among 1 currently registered trademark in the portfolio.

What is Topaz Pharmaceuticals LLC's trademark registration success rate?

Topaz Pharmaceuticals LLC has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.